# Identification of Key Genes Associated with Endoplasmic Reticulum Stress in Calcium Oxalate Kidney Stones

**Authors:** Zhenkun Tan, Wusheng She, Boqiang Wang, Xiang Wang, Xiaofeng Guan, Zhiwei Tao, Yaoliang Deng

PMC · DOI: 10.3390/genes16111338 · Genes · 2025-11-06

## TL;DR

This study identifies nine key genes linked to endoplasmic reticulum stress in calcium oxalate kidney stones, offering new insights for potential treatments.

## Contribution

The study identifies nine novel ERS-related genes in CaOx kidney stones using single-cell and transcriptomic analysis.

## Key findings

- Nine key genes (ACSL4, PTK2, DUSP4, MMP7, PHLDB2, TGM2, PPT1, SPARCL1, LTF) were identified as associated with ERS in CaOx kidney stones.
- A nomogram built from these genes showed strong predictive ability for CaOx kidney stone risk.
- qRT-PCR and Western blot confirmed significant expression changes in these genes in CaOx-exposed HK-2 cells.

## Abstract

Background: Previous studies have indicated an association between endoplasmic reticulum stress (ERS) and the formation of kidney stones. To further investigate this mechanism, this research sought to identify key genes linked to ERS in calcium oxalate (CaOx) kidney stones. Methods: Key cells with the highest ERS-related gene (ERSRG) scores were identified through single-cell analysis. These key cells were then categorized into high- and low-score groups based on their average ERSRG scores. To identify key genes, we analyzed the intersection of key ERSRGs and differentially expressed genes (DEGs) within key cells, focusing on genes demonstrating significant expression differences between control and CaOx kidney stone samples. A nomogram was constructed using these key genes to predict the risk of CaOx kidney stones. Gene set enrichment analysis (GSEA) was further performed to explore the functions of these key genes in the disease. Additionally, secondary clustering analysis was conducted on key cells to identify subtypes and evaluate the expression of key genes within these subtypes. Finally, the identified key genes were validated using quantitative real-time PCR (qRT-PCR) and Western blot analysis on cultured HK-2 cells, which were exposed with 2 mM CaOx for 24 h at 37 °C with 5% CO2 or incubated with regular culture medium. Results: Endothelial cells were identified as key cells, and nine key genes were pinpointed in CaOx kidney stones: ACSL4, PTK2, DUSP4, MMP7, PHLDB2, TGM2, PPT1, SPARCL1, and LTF. The nomogram developed from these key genes demonstrated robust predictive ability for CaOx kidney stones risk. Additionally, GSEA revealed that olfactory transduction was enriched by key genes except PTK2. Secondary clustering analysis identified four key cell subtypes within endothelial cells, with LTF, MMP7, and SPARCL1 showing significantly differential expression between control and CaOx kidney stones groups across all key cell subtypes. qRT-PCR and Western blot analyses revealed that, compared to the control group, CaOx-exposed HK-2 cells exhibited significantly increased expression of ACSL4, MMP7, TGM2, PPT1, and LTF (p < 0.05), while showing significantly decreased expression of PTK2, DUSP4, SPARCL1, and PHLDB2 (p < 0.05). Conclusions: This study identified key genes associated with ERS in CaOx kidney stones through single-cell and transcriptomic analysis. The discovery of these genes provides new insights into the treatment of CaOx kidney stones and offers valuable references for subsequent research. Future research should focus on elucidating the precise roles of these candidate genes in CaOx stone pathogenesis to assess their potential for therapeutic intervention.

## Linked entities

- **Genes:** ACSL4 (acyl-CoA synthetase long chain family member 4) [NCBI Gene 2182], PTK2 (protein tyrosine kinase 2) [NCBI Gene 5747], DUSP4 (dual specificity phosphatase 4) [NCBI Gene 1846], MMP7 (matrix metallopeptidase 7) [NCBI Gene 4316], PHLDB2 (pleckstrin homology like domain family B member 2) [NCBI Gene 90102], TGM2 (transglutaminase 2) [NCBI Gene 7052], PPT1 (palmitoyl-protein thioesterase 1) [NCBI Gene 5538], SPARCL1 (SPARC like 1) [NCBI Gene 8404], LTF (lactotransferrin) [NCBI Gene 4057]
- **Chemicals:** doxorubicin (PubChem CID 31703)

## Full-text entities

- **Genes:** PTK2 (protein tyrosine kinase 2) [NCBI Gene 5747] {aka FADK, FADK 1, FAK, FAK1, FRNK, PPP1R71}, ACSL4 (acyl-CoA synthetase long chain family member 4) [NCBI Gene 2182] {aka ACS4, FACL4, LACS4, MRX63, MRX68, XLID63}, DUSP4 (dual specificity phosphatase 4) [NCBI Gene 1846] {aka HVH2, MKP-2, MKP2, TYP}, PHLDB2 (pleckstrin homology like domain family B member 2) [NCBI Gene 90102] {aka LL5b, LL5beta}, PPT1 (palmitoyl-protein thioesterase 1) [NCBI Gene 5538] {aka CLN1, INCL, PPT}, MMP7 (matrix metallopeptidase 7) [NCBI Gene 4316] {aka MMP-7, MPSL1, PUMP-1}, LTF (lactotransferrin) [NCBI Gene 4057] {aka GIG12, HEL110, HLF2, LF}, SPARCL1 (SPARC like 1) [NCBI Gene 8404] {aka MAST 9, MAST9, PIG33, SC1}, TGM2 (transglutaminase 2) [NCBI Gene 7052] {aka G(h), TG(C), TGC, hTG2, tTG}
- **Diseases:** CaOx kidney stones (MESH:D007669)
- **Chemicals:** CaOx (MESH:D002129), CO2 (MESH:D002245)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12651965/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12651965/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC12651965/full.md

---
Source: https://tomesphere.com/paper/PMC12651965